首頁
Cumberland Pharmaceuticals Inc

7月 2026Cumberland Pharmaceutica...的市場佔有率分析

健康 > 健康 - 其他

域名cumberlandpharma.com

成立年份1999

僱員51 - 200

年度營收$25M - $50M

Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc（包含公司地區）

cumberlandpharma.com

查看更多網站流量與參與度資訊

Cumberland Pharmaceuticals Inc截至 7月 2026 的總收入為 25M - 50M

Cumberland Pharmaceuticals Inc 熱門網域產生的總收入

Cumberland Pharmaceuticals Inc 熱門網域 3 年內的總收入

Cumberland Pharmaceuticals Inc 熱門網域的總收入

cumberlandpharma.com25M - 50M

透過銷售情報查看更多內容

Cumberland Pharmaceuticals Inc的熱門網域總造訪量

了解Cumberland Pharmaceuticals Inc市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

cumberlandpharma.com3.5K

透過銷售情報查看更多內容

Cumberland Pharmaceuticals Inc的熱門網域平均造訪時長

分析Cumberland Pharmaceuticals Inc參與度指標。

過去 3 個月平均造訪時長

子公司細目

cumberlandpharma.com00:01:50

透過銷售情報查看更多內容

Cumberland Pharmaceuticals Inc的熱門網域平均頁面瀏覽量

了解Cumberland Pharmaceuticals Inc如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

cumberlandpharma.com2.52

透過銷售情報查看更多內容

Cumberland Pharmaceuticals Inc按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

vandapharma.com公司名Vanda Pharmaceuticals, Inc.僱員201 - 500總部美國, 哥倫比亞特區, Washington年度營收$200M - $500M訪問總量15.1K健康 > 生物技術和製藥

使用的熱門技術Cumberland Pharmaceuticals Inc

这些是Cumberland Pharmaceuticals Inc顶级域名使用的行业网站技术

內容管理系統 (5)

WordPress

電子郵件服務 (3)

G Suite

付款與貨幣 (3)

PayPal

付費廣告 (2)

DoubleClick

更多技術

5

檢視所有

新聞與訊號來自Cumberland Pharmaceuticals Inc

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Cumberland Pharmaceuticals Inc. had revenue of $170K on Aug 4th '26.Cumberland Pharmaceuticals had a negative return on equity of 28.81% and a negative net margin of 34.40%.The business had revenue of $0.17 million during the quarter, compared to the consensus estimate of $8.50 million.

新聞Cumberland Pharmaceuticals Inc. had revenue of $9.13M on May 5th '26.Cumberland Pharmaceuticals had a negative return on equity of 12.01% and a negative net margin of 17.60%.The business had revenue of $9.13 million for the quarter, compared to the consensus estimate of $8.50 million.

新聞Cumberland Pharmaceuticals Inc. launched Vibativ injection in China on May 28th '26.NASHVILLE, Tenn., May 28, 2026 /PRNewswire/ - Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation focused biopharmaceutical company, today announced the launch of its Vibativ(R)(telavancin) injection in China, following regulatory approval and a strategic partnership with SciClone Pharmaceuticals (Holdings) Limited.